Dr Hilary Tindle Discusses Use of the Nicotine Metabolite Ratio in Clinical Care
January 16th 2023Hilary Tindle, MD, MPH, associate professor of medicine, at Vanderbilt University, discusses how the nicotine metabolite ratio (NMR) can help inform doctors and patients on choosing the optimal treatment for quitting smoking.
Read More
Dr Hilary Tindle Breaks Down the Nicotine Metabolite Ratio
January 9th 2023Hilary Tindle, MD, MPH, associate professor of medicine, Vanderbilt University, discusses the nicotine metabolite ratio (NMR) is and how it's used to help identify vulnerable individuals for lung cancer and heart disease.
Read More
e-Cigarette Use Higher Among US-Born Hispanic and Latino Young Males With Higher Education
January 4th 2023A Hispanic community health study is the first of its kind to evaluate the prevalence and determinants of e-cigarette use among Hispanic and Latino populations living in the United States.
Read More
Dr Hilary Tindle Discusses NMR and Precision Approaches in Cancer Care
December 27th 2022Hilary Tindle, MD, MPH, associate professor of medicine, Vanderbilt University, spoke about the use of precision medicine approaches, such as the nicotine metabolite ratio (NMR), to improve outcomes for patients with lung cancer.
Read More
Neoadjuvant Immunotherapy Promising in CRC, but Long-term Data Needed, Says Dr Kristen Ciombor
December 24th 2022Kristen K Ciombor, MD, MSCI, associate professor at Vanderbilt University, explains that results of neoadjuvant immunotherapy in colorectal cancer are promising, but long-term data is still needed.
Read More
Postoperative TACE Prolongs RFS in Patients With Combined Hepatocellular-Cholangiocarcinoma
December 19th 2022Overall survival for patients with combined hepatocellular-cholangiocarcinoma is poor, but those who received adjuvant transarterial chemoembolization (TACE) after surgery had a prolonged recurrence-free survival (RFS).
Read More